[Effect of oral administration of epsilon-aminocaproic acid on serum lipids in patients with nephrotic syndrome].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood* / Q000188:drug therapy
D000614:Aminocaproates; D008055:Lipids
Wpływ doustnego stosowania kwasu epsilon-aminokapronowego na lipidy surowicy krwi u chorych z zespołlem nerczycowym.